TABLE 15.
Uncompetitive Antagonist | GluN2A | GluN2B | GluN2C | GluN2D |
---|---|---|---|---|
μM | ||||
(+)-MK-801 | 0.015 | 0.009 | 0.024 | 0.038 |
(−)-MK-801 | 0.35 | 0.32 | 0.038 | 0.17 |
(−)-Ketamine | 16 | 1.6 | 1.1 | 1.5 |
(±)-Norketamine | 51 | 8.7 | 5.6 | 7.5 |
Dextromethorphan | 11 | 3.7 | 1.1 | 5.4 |
Levomethorphan | 13 | 2.2 | 1.1 | 2.6 |
Dextrorphan | 1.3 | 0.33 | 0.15 | 0.74 |
Levorphanol | 1.8 | 1.2 | 0.58 | 2.1 |
Phencyclidine | 0.82 | 0.16 | 0.16 | 0.22 |
PCA | 19 | 3.9 | 1.6 | 1.7 |
CNS-1102 | 0.13 | 0.068 | 0.087 | 0.14 |
Amantadine | 130 | 70 | 35 | 38 |
Remacemide | 81 | 35 | 92 | 63 |
Pentamidine | 0.72 | 1.5 | 10 | 9.1 |
9-aminoacridine | 7.8 | 7.5 | 29 | 38 |
Memantine | 0.80 | 0.57 | 0.52 | 0.54 |
Memantine–1 mM Mg2+ | 13 | 10 | 1.6 | 1.8 |
(±)-Ketamine | 0.33 | 0.31 | 0.51 | 0.83 |
(±)-Ketamine–1 mM Mg2+ | 5.4 | 5.08 | 1.2 | 2.9 |
CNS-1102, aptiganel; PCA, 1-phenylcyclohexylamine.